Environmental testing for SARS-CoV-2 in three tertiary-care hospitals during the peak of the third COVID-19 wave.

B.1.1.7 COVID-19 Disinfection Environmental contamination Fomites Hospitals Inanimate surfaces SARS-CoV-2

Journal

American journal of infection control
ISSN: 1527-3296
Titre abrégé: Am J Infect Control
Pays: United States
ID NLM: 8004854

Informations de publication

Date de publication:
11 2021
Historique:
received: 20 05 2021
revised: 20 08 2021
accepted: 21 08 2021
pubmed: 30 8 2021
medline: 28 10 2021
entrez: 29 8 2021
Statut: ppublish

Résumé

Contamination of surfaces has been implicated in transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We tested by real-time PCR for SARS-CoV-2 contamination environmental samples from three hospitals during the peak of the third pandemic wave. Overall, 19 of 463 (4.1%) samples tested positive: 12 of 173 (6.9%) samples from a COVID-19 hospital, 3 of 177 (1.7%) samples from a non-COVID-19 hospital, and 4 of 113 (3.5%) samples from a pediatric hospital with dedicated COVID-19 clinics. Most positive samples originated from emergency departments (EDs) (47.3%) and the intensive care units (ICUs) (26.3%) of the COVID-19 hospital. Positive samples belonged almost exclusively (18/19) to the highly transmissible B.1.1.7 cluster, that might explain environmental contamination at this stage of the pandemic. The frequency and efficiency of disinfection in high-risk patient areas, such as EDs and ICUs, should be reinforced, especially during this period where highly transmissible variants of concern are widespread.

Identifiants

pubmed: 34455029
pii: S0196-6553(21)00558-7
doi: 10.1016/j.ajic.2021.08.022
pmc: PMC8388137
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1435-1437

Informations de copyright

Copyright © 2021 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Helena C Maltezou (HC)

Directorate of Research, Studies and Documentation, National Public Health Organization, Athens, Greece. Electronic address: helen-maltezou@ath.forthnet.gr.

Maria Tseroni (M)

Directorate of Research, Studies and Documentation, National Public Health Organization, Athens, Greece.

Charalampos Daflos (C)

Infection Control Committee, Red Cross General Hospital, Athens, Greece.

Cleo Anastassopoulou (C)

Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Antonios Vasilogiannakopoulos (A)

Infection Control Committee, Henry Dunant Hospital Center, Athens, Greece.

Olga Daligarou (O)

Infection Control Committee, Henry Dunant Hospital Center, Athens, Greece.

Maria Panagiotou (M)

Infection Control Committee, Henry Dunant Hospital Center, Athens, Greece.

Evanthia Botsa (E)

First Department of Pediatrics, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens, Greece.

Nikolaos Spanakis (N)

Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Athanasia Lourida (A)

Infection Control Committee, Aghia Sophia Children's Hospital, Athens, Greece.

Athanasios Tsakris (A)

Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH